Using AI to improve the potency of stem cells for therapy
AI-informed Signaling Factor Design for in vitro Rejuvenating Mesenchymal Stromal Cells
This study is looking at ways to make special cells called mesenchymal stromal cells (MSCs) even better for treating diseases by using artificial intelligence to find the best combinations of signals that can help keep these cells young and effective, which could lead to improved treatments for patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-10884454 on NIH RePORTER |
What this research studies
This research focuses on enhancing the effectiveness of mesenchymal stromal cells (MSCs), which are promising for treating various diseases. The project aims to use artificial intelligence to identify the right combinations of signaling factors that can delay or reverse the aging process of these cells when cultured in the lab. By understanding how to better manage the metabolic signaling pathways that lead to cell senescence, the researchers hope to produce more potent MSCs for clinical use. Patients may benefit from therapies derived from these improved cells, which could lead to better treatment outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that could benefit from stem cell therapies, such as degenerative diseases or injuries.
Not a fit: Patients who do not have conditions treatable by stem cell therapies may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective stem cell therapies for a range of diseases.
How similar studies have performed: Other research has shown promise in using AI to optimize cell therapies, indicating that this approach could be successful.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Lin, Neil — University of California Los Angeles
- Study coordinator: Lin, Neil
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.